It is a business services private limited company based in Pune, Maharashtra, India, established in 2011.
2011 | Pune, Maharashtra, India | ActiveGxp Pharmaceuticals Private Limited, a active private limited company, was established on 15 October 2011 in Pune, Maharashtra, India. Engaging in business support services within the support service to organizations sector, it holds CIN: U85191PN2011PTC156428. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 14 professional, Its leadership includes Aryan Puri (Director), Anand Virendra Jain (Director), Sanjiv Puri (Managing Director). Past directors included Chanda Abhay Peshave, Aryan Puri, Davinder Singh Brar. It holds no open charges and ₹9.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4Th Floor, Vedwati Apartment, Bhavkar Bhavan Lane Shivaji Nagar, Pune, Maharashtra, 411005.
U85191PN2011PTC156428
156428
15 October 2011
₹0.50 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Gxp Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aryan Puri | Director | 29 Dec 2020 | Current |
| Anand Virendra Jain | Director | 01 Mar 2021 | Current |
| Sanjiv Puri | Managing Director | 15 Oct 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Nov 2017 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 29 Oct 2013 | Past |
| Pramod Abcsdd | Director | 06 Nov 2014 | Past |
| Pramod Abcsdd | Additional Director | 16 Sep 2022 | Past |
| Pramod Abcsdd | Director | 01 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gxp Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 84.19% increase in profit. The company's net worth dipped by a decrease of 9.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Gxp Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹95,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2014 | Gvk Biosciences Private Limited | ₹9.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Gxp Pharmaceuticals has a workforce of 14 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gxp Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gxp Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gxp Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Gxp Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
Progress on Anand Virendra Jain was appointed as a Director was appointed as a Director on 01 Mar 2021 & has been associated with this company since 4 years 9 months . was documented.
Aryan Puri was appointed as a Director was appointed as a Director on 29 Dec 2020 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
A charge registered on 05 May 2014 via Charge ID 10524286 with Gvk Biosciences Private Limited was fully satisfied on 14 Apr 2016. was recorded as a recent event.
Progress on A charge with Gvk Biosciences Private Limited amounted to Rs. 95.00 M with Charge ID 10524286 was registered on 05 May 2014. was documented.
The CIN of Gxp Pharmaceuticals Private Limited is U85191PN2011PTC156428.
Gxp Pharmaceuticals Private Limited is headquartered at 4Th Floor, Vedwati Apartment, Bhavkar Bhavan Lane Shivaji Nagar, Pune, Maharashtra, 411005.
Gxp Pharmaceuticals Private Limited was incorporated on 15 October 2011.
The current directors of Gxp Pharmaceuticals Private Limited are
The primary industry of Gxp Pharmaceuticals Private Limited is Support Service To Organizations.
Gxp Pharmaceuticals Private Limited is unlisted.
The authorized capital of Gxp Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Gxp Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX